Gold nanoparticles as novel agents for cancer therapy
Top Cited Papers
- 1 February 2012
- journal article
- review article
- Published by Oxford University Press (OUP) in The British Journal of Radiology
- Vol. 85 (1010) , 101-113
- https://doi.org/10.1259/bjr/59448833
Abstract
Gold nanoparticles are emerging as promising agents for cancer therapy and are being investigated as drug carriers, photothermal agents, contrast agents and radiosensitisers. This review introduces the field of nanotechnology with a focus on recent gold nanoparticle research which has led to early-phase clinical trials. In particular, the pre-clinical evidence for gold nanoparticles as sensitisers with ionising radiation in vitro and in vivo at kilovoltage and megavoltage energies is discussed.Keywords
This publication has 82 references indexed in Scilit:
- Translational considerations for cancer nanomedicineJournal of Controlled Release, 2010
- Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre studyThe Lancet Oncology, 2010
- Nanotechnology in Head and Neck Cancer: The Race Is OnCurrent Oncology Reports, 2010
- Fabrication of gold nanoparticles for targeted therapy in pancreatic cancerAdvanced Drug Delivery Reviews, 2009
- The dosimetric feasibility of gold nanoparticle-aided radiation therapy (GNRT) via brachytherapy using low-energy gamma-/x-ray sourcesPhysics in Medicine & Biology, 2009
- Cetuximab plus gemcitabine/oxaliplatin (GEMOXCET) in first-line metastatic pancreatic cancer: a multicentre phase II studyBritish Journal of Cancer, 2009
- Targeted Delivery of Gemcitabine to Pancreatic Adenocarcinoma Using Cetuximab as a Targeting AgentCancer Research, 2008
- Cell selective response to gold nanoparticlesPublished by Elsevier ,2007
- FDG-PET for lymph node staging in NSCLC: a major step forward, but beware of the pitfallsLung Cancer, 2005
- Image enhancement in computerized tomography for sensitive diagnosis of liver cancer and semiquantitation of tumor selective drug targeting with oily contrast mediumCancer, 1985